← Leaderboards
Malay Choudhury
Mayo Clinic Rochester
$1,908,593
Attributed
$1,908,593
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $511.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,908,593 · 2
By mechanism
R01$1,511,094 · 1
R56$397,499 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Daniel J. Tschumperlin$19,462,790
- Carlos B Mantilla$9,702,168
- Hu Zeng$3,944,442
- Scott H Kaufmann$29,002,745
- Giovanni Ligresti$4,830,216
Others in their field
Other Rising Stars on “Chronic”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- James Cappo · National Jewish Health$9,298,220
- Christine W Hockett · Avera Mckennan$8,908,366
- Iii, Josiah J. Sampson · Tougaloo College$8,000,000
- Rosianna R Gray · Stillman College$7,999,408
Research focus
ChronicC-Myc GenesAgedAdultAgingAmino Acid TransporterAnchorage-Independent GrowthApoptosisAmino Acid MetabolismAttenuatedAutomobile DrivingAmino AcidsBcl2 GeneBiogenesisBiologicalBiomassBleomycinCell GrowthCell MotilityCell ProliferationCellsCellular TargetingCessation Of LifeConditional Knockout
Grant awards (5)
Targeting the Amino Acid Transporter SLC7A5 for Pulmonary Fibrosis$511,293
R01 · FY2025 · HL · contact PI
Targeting the Amino Acid Transporter SLC7A5 for Pulmonary Fibrosis$498,780
R01 · FY2024 · HL · contact PI
Targeting the Amino Acid Transporter SLC7A5 for Pulmonary Fibrosis$501,021
R01 · FY2023 · HL · contact PI
Targeting the Amino Acid Transporter SLC7A5 for Treatment of Pulmonary Fibrosis$201,767
R56 · FY2022 · HL · contact PI
Targeting the Amino Acid Transporter SLC7A5 for Treatment of Pulmonary Fibrosis$195,732
R56 · FY2022 · HL · contact PI